Olsson H - Search Results

1

CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women.

Henningson M, Johansson U, Borg A, Olsson H, Jernström H. Henningson M, et al. Among authors: olsson h. Mol Hum Reprod. 2007 Apr;13(4):231-6. doi: 10.1093/molehr/gam004. Epub 2007 Feb 16. Mol Hum Reprod. 2007. PMID: 17307805

2

Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis.

Borg A, Zhang QX, Olsson H, Wenngren E. Borg A, et al. Among authors: olsson h. Genes Chromosomes Cancer. 1992 Nov;5(4):311-20. doi: 10.1002/gcc.2870050406. Genes Chromosomes Cancer. 1992. PMID: 1283319

3

Plasma prolactin in relation to menstrual cycle phase, oral contraceptive use, arousal time and smoking habits.

Jernström H, Knutsson M, Taskila P, Olsson H. Jernström H, et al. Among authors: olsson h. Contraception. 1992 Dec;46(6):543-8. doi: 10.1016/0010-7824(92)90119-e. Contraception. 1992. PMID: 1493714

4

The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.

Borg A, Zhang QX, Alm P, Olsson H, Sellberg G. Borg A, et al. Among authors: olsson h. Cancer Res. 1992 May 15;52(10):2991-4. Cancer Res. 1992. PMID: 1581913

5

c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.

Borg A, Baldetorp B, Fernö M, Olsson H, Sigurdsson H. Borg A, et al. Among authors: olsson h. Int J Cancer. 1992 Jul 9;51(5):687-91. doi: 10.1002/ijc.2910510504. Int J Cancer. 1992. PMID: 1612775

6

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.

Fernö M, Baldetorp B, Borg A, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Among authors: olsson h. Acta Oncol. 1992;31(2):157-65. doi: 10.3109/02841869209088897. Acta Oncol. 1992. PMID: 1622630

7

ERBB2 amplification in breast cancer with a high rate of proliferation.

Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H. Borg A, et al. Among authors: olsson h. Oncogene. 1991 Jan;6(1):137-43. Oncogene. 1991. PMID: 1671531

8

Survival in breast cancer and age at start of oral contraceptive usage.

Ranstam J, Olsson H, Garne JP, Aspegren K, Janzon L. Ranstam J, et al. Among authors: olsson h. Anticancer Res. 1991 Nov-Dec;11(6):2043-6. Anticancer Res. 1991. PMID: 1776838

9

Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden.

Olsson H, Borg A, Fernö M, Möller TR, Ranstam J. Olsson H, et al. Cancer Detect Prev. 1991;15(4):265-71. Cancer Detect Prev. 1991. PMID: 1794133

10

Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones.

Olsson H, Borg A, Fernö M, Ranstam J, Sigurdsson H. Olsson H, et al. J Natl Cancer Inst. 1991 Oct 16;83(20):1483-7. doi: 10.1093/jnci/83.20.1483. J Natl Cancer Inst. 1991. PMID: 1920494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

888 results

Search Page

Filters